Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

Verrica Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference

WEST CHESTER, Pa., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing and selling medications for skin diseases requiring medical interventions, today announced that Jayson Rieger, PhD, MBA, President and Chief Executive…

Beacon Therapeutics to Participate in TD Cowen's 46th Annual Health Care Conference - Beacon Therapeutics

Related posts: Beacon Therapeutics Presents 36-Month Interim Results from Phase I/2 HORIZON Trial of laru-zova (AGTC-501) in Patients with XLRP Beacon Therapeutics Announces Positive 24-Month Data from Phase 2 SKYLINE Trial of laru-zova (AGTC-501) in Patients with X-Linked Retinitis Pigmentosa Beacon Therapeutics to Participate in the 2025 Bank of America Healthcare Trailblazers Private Company Conference […]